Skip to main content
. 2020 Sep 4;69(5):1–18. doi: 10.15585/mmwr.ss6905a1

TABLE 3. Timeliness of Community Counts surveillance procedures — 2018*,†.

Timeliness indicator No. (%)
No. of days between visit date and submission of clinical data to CDC (via ATHN)

<15
3,859 (60.1)
15–29
1,031 (16.0)
30–59
712 (11.1)
≥60
824 (12.8)
No. of days between submission to CDC and availability to public via data visualization platform
Data visualization data set updated monthly
No. of days between visit date and submission of laboratory specimen to CDC hemostasis laboratory

<15
5,924 (71.1)
15–29
1,219 (14.6)
30–59
706 (8.5)
≥60
485 (5.8)
No. of days between receipt by CDC hemostasis laboratory and reporting of results back to HTC

<15
7,803 (93.6)
15–29
337 (4.0)
30–59
84 (1.0)
≥60 110 (1.3)

Abbreviations: ATHN = American Thrombosis and Hemostasis Network; HTC = hemophilia treatment center.

* Some percentages might not total 100% due to rounding.

The total number of hemophilia visits reported to the Community Counts patient registry in 2018 was 6,426. Of these, laboratory specimens were submitted for 5,357 persons. Because more than one specimen could be submitted per person, the total number of specimens submitted to and tested by the CDC laboratory was 8,334.